Rachel Klemovitch, Assistant Editor02.05.24
Solesis, medical device and biopharmaceutical manufacturer, has announced plans to build a new manufacturing site in Costa Rica. The is the company’s first site dedicated to producing polymer-based devices and components, implantable textile components, and single-use technologies.
“Expanding into Costa Rica will significantly increase our global capacity, enabling us to rapidly expand and optimize our resources to provide our customers with comprehensive business continuity avenues that mitigate supply chain risks,” said Solesis CEO, Jeff Robertson. “Costa Rica is a global medical device hub and a prime location for expanding the production of our critical healthcare solutions. In fact, many of our customers already have established manufacturing operations in this region and we look forward to continued collaboration with them.”
The new site will include cleanrooms that will produce Solesis’ healthcare products. Operations are scheduled to begin in the spring of 2025 in the Greenpark Free Trade Zone, Latin Americas first environmentally sustainable industrial park and Free Trade Zone.
“This expansion is a significant milestone for Solesis and we are looking forward to being part of the San Jose community. We are excited to work with the strong talent pool that lives in Costa Rica and plan to announce which roles we will be recruiting for in the latter half of 2024,” said Lindsay Walker, VP of Human Resources of Solesis.
Costa Rica’s Minister of Foreign Trade, Manuel Tovar commented, "We extend a warm welcome to Solesis as a significant contributor to the rapidly expanding medical devices industry in our country. Our leadership, talent pool, extensive experience, and sterling reputation in the precision and medical equipment sector (constituting 42% of the country's exports in 2023) have inspired confidence, leading companies such as Solesis to choose Costa Rica as the location for establishing their facility.”
“Expanding into Costa Rica will significantly increase our global capacity, enabling us to rapidly expand and optimize our resources to provide our customers with comprehensive business continuity avenues that mitigate supply chain risks,” said Solesis CEO, Jeff Robertson. “Costa Rica is a global medical device hub and a prime location for expanding the production of our critical healthcare solutions. In fact, many of our customers already have established manufacturing operations in this region and we look forward to continued collaboration with them.”
The new site will include cleanrooms that will produce Solesis’ healthcare products. Operations are scheduled to begin in the spring of 2025 in the Greenpark Free Trade Zone, Latin Americas first environmentally sustainable industrial park and Free Trade Zone.
“This expansion is a significant milestone for Solesis and we are looking forward to being part of the San Jose community. We are excited to work with the strong talent pool that lives in Costa Rica and plan to announce which roles we will be recruiting for in the latter half of 2024,” said Lindsay Walker, VP of Human Resources of Solesis.
Costa Rica’s Minister of Foreign Trade, Manuel Tovar commented, "We extend a warm welcome to Solesis as a significant contributor to the rapidly expanding medical devices industry in our country. Our leadership, talent pool, extensive experience, and sterling reputation in the precision and medical equipment sector (constituting 42% of the country's exports in 2023) have inspired confidence, leading companies such as Solesis to choose Costa Rica as the location for establishing their facility.”